Resultats de la cerca - Sara Charmsaz
- Mostrar 1 - 3 resultats de 3
-
1
-
2
Nuclear factor one B (<i>NFIB</i>) encodes a subtype-specific tumour suppressor in glioblastoma per Brett W. Stringer, Jens Bunt, Bryan W. Day, Guy Barry, Paul R. Jamieson, Kathleen S. Ensbey, Zara C. Bruce, Kate Goasdoué, Hélène Vidal, Sara Charmsaz, Fiona Smith, Leanne Cooper, Michael Piper, Andy Boyd, Linda J. Richards
Publicat 2016Artigo -
3
EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme per Bryan W. Day, Brett W. Stringer, Fares Al‐Ejeh, Michael J. Ting, John C. Wilson, Kathleen S. Ensbey, Paul R. Jamieson, Zara C. Bruce, Yi Chieh Lim, Carolin Offenhäuser, Sara Charmsaz, Leanne Cooper, Jennifer K. Ellacott, Angus Harding, Lucie Leveque, Po Inglis, Suzanne Allan, David G. Walker, Martin Lackmann, Geoffrey W. Osborne, Kum Kum Khanna, Brent A. Reynolds, Jason D. Lickliter, Andy Boyd
Publicat 2013Artigo
Eines de cerca:
Matèries relacionades
Biology
Cancer
Medicine
Cancer research
Glioblastoma
Internal medicine
Antibody
Bioinformatics
Cancer therapy
Cancer treatment
Cell biology
Cell culture
Environmental health
Gene knockdown
Genetics
Glioma
Immunology
Monoclonal antibody
Nursing
Oncology
Pathology
Population
Precision medicine
Quality of life (healthcare)
Radiation therapy
Receptor
Receptor tyrosine kinase
Signal transduction
Suppressor
Tyrosine kinase